The Times of Israel reports: A private Israeli hospital in Haifa will start using IceCure Medical Ltd.’s tumor freezing technology within the next few months to fight benign breast tumors and cancerous kidney tumors without the need for surgery, the Israeli medical devices firm said.
The firm, whose shares are traded on the Tel Aviv Stock Exchange, said Wednesday that commercial treatment of its product will start for the first time in Israel at the Elisha Hospital, using the startup’s ProSense system.
IceCure in May reported (Hebrew) results of a breast cancer trial that showed a low rate of cancer recurrence of cancer after treatment using its IceSense3 system, an earlier version of ProSense.
Read more here.